Search

Financial results - EVOLDA MED S.R.L.

0.00
Financial Summary - Evolda Med S.r.l.
Unique identification code: 46991769
Registration number: J2022020209407
Nace: 4646
Sales - Ron
4.813.378
Net Profit - Ron
444.457
Employees
1
Open Account
Company Evolda Med S.r.l. with Fiscal Code 46991769 recorded a turnover of 2024 of 4.813.378, with a net profit of 444.457 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Evolda Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 52.105 275.493 4.813.378
Total Income - EUR - - - - - - - 52.105 275.528 4.813.380
Total Expenses - EUR - - - - - - - 38.959 178.099 4.309.568
Gross Profit/Loss - EUR - - - - - - - 13.146 97.429 503.812
Net Profit/Loss - EUR - - - - - - - 12.625 95.087 444.457
Employees - - - - - - - 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1,657.0%, from 275.493 euro in the year 2023, to 4.813.378 euro in 2024. The Net Profit increased by 349.902 euro, from 95.087 euro in 2023, to 444.457 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Evolda Med S.r.l.

Rating financiar

Financial Rating -
EVOLDA MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Evolda Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Evolda Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Evolda Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Evolda Med S.r.l. - CUI 46991769

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 129 28.054 26.768
Current Assets - - - - - - - 66.576 128.319 5.307.805
Inventories - - - - - - - 27.954 43.075 23.059
Receivables - - - - - - - 38.423 84.391 5.274.412
Cash - - - - - - - 200 854 10.333
Shareholders Funds - - - - - - - 12.665 95.627 460.023
Social Capital - - - - - - - 41 40 40
Debts - - - - - - - 54.040 60.746 4.874.576
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.307.805 euro in 2024 which includes Inventories of 23.059 euro, Receivables of 5.274.412 euro and cash availability of 10.333 euro.
The company's Equity was valued at 460.023 euro, while total Liabilities amounted to 4.874.576 euro. Equity increased by 364.930 euro, from 95.627 euro in 2023, to 460.023 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Evolda Med S.r.l.

Comments - Evolda Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.